371 related articles for article (PubMed ID: 25669441)
1. Sclerostin and skeletal health.
Sharifi M; Ereifej L; Lewiecki EM
Rev Endocr Metab Disord; 2015 Jun; 16(2):149-56. PubMed ID: 25669441
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
Sebastian A; Loots GG
Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
[TBL] [Abstract][Full Text] [Related]
3. Anti-sclerostin antibodies: utility in treatment of osteoporosis.
Clarke BL
Maturitas; 2014 Jul; 78(3):199-204. PubMed ID: 24842796
[TBL] [Abstract][Full Text] [Related]
4. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
[TBL] [Abstract][Full Text] [Related]
6. Anti-sclerostin - is there an indication?
Larsson S
Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288
[TBL] [Abstract][Full Text] [Related]
7. Update on romosozumab : a humanized monoclonal antibody to sclerostin.
Costa AG; Bilezikian JP; Lewiecki EM
Expert Opin Biol Ther; 2014 May; 14(5):697-707. PubMed ID: 24665957
[TBL] [Abstract][Full Text] [Related]
8. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.
ten Dijke P; Krause C; de Gorter DJ; Löwik CW; van Bezooijen RL
J Bone Joint Surg Am; 2008 Feb; 90 Suppl 1():31-5. PubMed ID: 18292354
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders.
Pietrzyk B; Smertka M; Chudek J
Adv Clin Exp Med; 2017 Nov; 26(8):1283-1291. PubMed ID: 29264888
[TBL] [Abstract][Full Text] [Related]
10. [Bone and Nutrition. Sclerostin and bone metabolism].
Tatsumi S; Nagamoto K; Ogata M; Miyamoto K
Clin Calcium; 2015 Jul; 25(7):1043-7. PubMed ID: 26119318
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin: a novel target for intervention in the treatment of osteoporosis.
Lewiecki EM
Discov Med; 2011 Oct; 12(65):263-73. PubMed ID: 22031665
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis.
Robinson MK; Caminis J; Brunkow ME
Drug Discov Today; 2013 Jul; 18(13-14):637-43. PubMed ID: 23579167
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin: recent advances and clinical implications.
Honasoge M; Rao AD; Rao SD
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):437-46. PubMed ID: 25333305
[TBL] [Abstract][Full Text] [Related]
14. Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases.
Lewiecki EM
Ther Adv Musculoskelet Dis; 2014 Apr; 6(2):48-57. PubMed ID: 24688605
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin deficiency in humans.
van Lierop AH; Appelman-Dijkstra NM; Papapoulos SE
Bone; 2017 Mar; 96():51-62. PubMed ID: 27742500
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin: therapeutic horizons based upon its actions.
Costa AG; Bilezikian JP
Curr Osteoporos Rep; 2012 Mar; 10(1):64-72. PubMed ID: 22234741
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin and Bone Aging: A Mini-Review.
Hay E; Bouaziz W; Funck-Brentano T; Cohen-Solal M
Gerontology; 2016; 62(6):618-623. PubMed ID: 27177738
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin: from bench to bedside.
Tanaka S; Matsumoto T
J Bone Miner Metab; 2021 May; 39(3):332-340. PubMed ID: 33206222
[TBL] [Abstract][Full Text] [Related]
19. Targeting sclerostin as potential treatment of osteoporosis.
Papapoulos SE
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
[TBL] [Abstract][Full Text] [Related]
20. Romosozumab for the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Biol Ther; 2017 Feb; 17(2):255-263. PubMed ID: 28064540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]